GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
8DLX | 8DLX | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 | |
8DLW | 8DLW | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 | |
8DLS | 8DLS | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) | |
8DLR | 8DLR | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8) | |
8DK6 | 8DK6 | Structure of hepatitis C virus envelope N-terminal truncated glycoprotein 2 (E2) (residues 456-713) from J6 genotype | |
8DIU | 8DIU | Cryo-EM structure of influenza A virus A/Bayern/7/1995 hemagglutinin bound to CR6261 Fab | |
8DIS | 8DIS | CryoEM structure of Influenza A virus A/Melbourne/1/1946 (H1N1) hemagglutinin bound to CR6261 Fab | |
8DIM | 8DIM | CryoEM structure of Influenza A virus A/Ohio/09/2015 hemagglutinin bound to CR6261 Fab | |
8DI5 | 8DI5 | Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6) | |
8DG9 | 8DG9 | Cryo-EM Structure of RSV prefusion F trimer in complex with three MxR Fabs | |
8DG8 | 8DG8 | Cryo-EM Structure of HPIV3 prefusion F trimer in complex with 3x1 Fab | |
8DFW | 8DFW | Crystal Structure of Human BTN2A1 in Complex With Vgamma9-Vdelta2 T Cell Receptor | |
8DF5 | 8DF5 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
8DF1 | 8DF1 | Chi3l1 bound by antibody C59 | |
8DER | 8DER | Cryo-EM local refinement of antibody SKV16 in complex with VEEV alphavirus spike glycoprotein | |
8DEQ | 8DEQ | Cryo-EM local refinement of antibody SKV09 in complex with VEEV alphavirus spike glycoprotein | |
8DE6 | 8DE6 | Oligomeric C9 in complex with aE11 Fab | |
8DE4 | 8DE4 | Native serotonin transporter in complex with 15B8 Fab in the presence of methamphetamine | |
8DE3 | 8DE3 | Native serotonin transporter in complex with 15B8 Fab antibody in the presence of cocaine | |
8DDK | 8DDK | CCHFV GP38 Hoti/Kosovo bound with CC5_17 | |
8DD3 | 8DD3 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus DMCM | |
8DD2 | 8DD2 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem | |
8DCY | 8DCY | CCHFV GP38 Hoti/Kosovo bound with 13G8 Fab | |
8DCC | 8DCC | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
8DAD | 8DAD | SARS-CoV-2 receptor binding domain in complex with AZ090 Fab | |
8D8R | 8D8R | SARS-CoV-2 Spike RBD in complex with DMAb 2196 | |
8D8Q | 8D8Q | SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196 | |
8D7E | 8D7E | Cryo-EM structure of human CNTFR alpha in complex with the Fab fragments of two antibodies | |
8D5N | 8D5N | Crystal structure of Ld-HF10 | |
8D53 | 8D53 | Crystal Structure of Mosaic HIV-1 Envelope (MosM3.3) in Complex with antibodies PGT124 and 35O22 at 3.25 Angstrom | |
8D50 | 8D50 | Crystal Structure of Mosaic HIV-1 Envelope (MosM3.1) in Complex with antibodies PGT124 and 35O22 at 4.3 Angstrom | |
8D4R | 8D4R | Crystal Structure of Mosaic HIV-1 Envelope (MosM3.2) in Complex with antibodies PGT124 and 35O22 at 3.8 Angstrom | |
8D48 | 8D48 | sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein | |
8D3A | 8D3A | Crystal Structure of DH475 Fab in complex with Man9 | |
8D2X | 8D2X | Zebrafish MFSD2A isoform B in inward open ligand 3C conformation | |
8D2W | 8D2W | Zebrafish MFSD2A isoform B in inward open ligand 2B conformation | |
8D2V | 8D2V | Zebrafish MFSD2A isoform B in inward open ligand 1B conformation | |
8D2U | 8D2U | Zebrafish MFSD2A isoform B in inward open ligand 1A conformation | |
8D2T | 8D2T | Zebrafish MFSD2A isoform B in inward open ligand-free conformation | |
8D2S | 8D2S | Zebrafish MFSD2A isoform B in inward open ligand bound conformation | |
8D21 | 8D21 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
8D0Z | 8D0Z | S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) | |
8D0Y | 8D0Y | Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom | |
8CZZ | 8CZZ | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with Temsavir, 8ANC195, and 10-1074 | |
8CYH | 8CYH | Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics | |
8CYB | 8CYB | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 | |
8CYA | 8CYA | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 | |
8CY7 | 8CY7 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 | |
8CXN | 8CXN | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 | |
8CXI | 8CXI | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024